Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATE-BLOCK: Carvedilol vs Metoprolol in ACS
NCT02809820Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in acute coronary syndrome (ACS) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: Platelet aggregation at 30 days. Started May 2016; status: completed.
02
Drugs
carvedilol
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02809820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809820.